{"transactions":[{"id":832727,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56927,"kind":"person","name":"Brown Martin S JR","position":1,"cik":"0001362521","reported_name":"Brown Martin S JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T21:24:05.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":2.8,"value":5040.0,"ownership":{"direct":true},"balance_after":10300,"source":{"system":"sec-edgar","filing":"0001087294-26-000040","document":"wk-form4_1774041843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000040/wk-form4_1774041843.xml","form_type":"4"}},{"id":1201686,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56927,"kind":"person","name":"Brown Martin S JR","position":1,"cik":"0001362521","reported_name":"Brown Martin S JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T21:12:38.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":5.17,"value":5170.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 17, 2026."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001628280-25-013538","document":"wk-form4_1742332351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025013538/wk-form4_1742332351.xml","form_type":"4"}},{"id":1291108,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56927,"kind":"person","name":"Brown Martin S JR","position":1,"cik":"0001362521","reported_name":"Brown Martin S JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-30T21:40:22.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":1.71,"value":4275.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed solely to correct an administrative error in reporting the number of Securities  Acquired by Reporting Owner on the original Form 4 submitted on March 26, 2024, which were reported as 1,000 shares granted on March 25, 2024, but should have been reported as 2,500 shares.  This reflects an increase of 1,500 shares."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001628280-25-003186","document":"wk-form4a_1738273215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025003186/wk-form4a_1738273215.xml","form_type":"4/A","original_submission_date":"2024-03-26"}},{"id":1561041,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56927,"kind":"person","name":"Brown Martin S JR","position":1,"cik":"0001362521","reported_name":"Brown Martin S JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-27T00:29:56.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":1.71,"value":1710.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 25, 2025."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001214659-24-005219","document":"marketforms-65377.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000121465924005219/marketforms-65377.xml","form_type":"4"}},{"id":1938307,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56927,"kind":"person","name":"Brown Martin S JR","position":1,"cik":"0001362521","reported_name":"Brown Martin S JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-27T21:41:55.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":1.97,"value":1970.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 24, 2024"}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-23-021280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919123021280/doc4.xml","form_type":"4"}}]}